Anxiety Peptide |
| Catalog No.GA20775 |
Anxiety peptide (ODN), which corresponds to diazepam binding inhibitor (DBI) (33-50), is produced by tryptic digestion of DBI. The octadecapeptide binds to the benzodiazepine receptor and appears to increase anxiety. De Mateos-Verchere et al. showed that ODN exerts potent anorexigenic effects in rodents. See also H-6760.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 95237-86-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Anxiety peptide (ODN), which corresponds to diazepam binding inhibitor (DBI) (33-50), is produced by tryptic digestion of DBI. The octadecapeptide binds to the benzodiazepine receptor and appears to increase anxiety. De Mateos-Verchere et al. showed th
Average Rating: 5 (Based on Reviews and 16 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *